source
- Abiomed recalls Impella CP Sets with SmartAssist over low purge pressure riskAbiomed has issued a recall of specific Impella CP Sets with SmartAssist after discovering that the units do not meet design specifications. The defect can cause low purge pressure events from the…
- Scribe Therapeutics files for Nasdaq IPO, testing market appetite for early-stage gene-editing firmsScribe Therapeutics announced it has filed a registration statement to list its shares on the Nasdaq, marking the company’s first step toward a public offering. The filing highlights the growing i…